BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30987206)

  • 1. Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications.
    Tyo KM; Minooei F; Curry KC; NeCamp SM; Graves DL; Fried JR; Steinbach-Rankins JM
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30987206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrospun fibers for vaginal anti-HIV drug delivery.
    Blakney AK; Ball C; Krogstad EA; Woodrow KA
    Antiviral Res; 2013 Dec; 100 Suppl():S9-16. PubMed ID: 24188701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Modeling of Antiviral Drug Diffusion from Poly(lactic- co-glycolic-acid) Fibers and Multicompartment Pharmacokinetics for Application to the Female Reproductive Tract.
    Halwes ME; Tyo KM; Steinbach-Rankins JM; Frieboes HB
    Mol Pharm; 2018 Apr; 15(4):1534-1547. PubMed ID: 29481088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of electrospun fibers for female reproductive health.
    Blakney AK; Jiang Y; Woodrow KA
    Drug Deliv Transl Res; 2017 Dec; 7(6):796-804. PubMed ID: 28497376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling of nanoparticle transport through the female reproductive tract for the treatment of infectious diseases.
    Sims LB; Miller HA; Halwes ME; Steinbach-Rankins JM; Frieboes HB
    Eur J Pharm Biopharm; 2019 May; 138():37-47. PubMed ID: 30195726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrospun fiber-mediated delivery of neurotrophin-3 mRNA for neural tissue engineering applications.
    Puhl DL; Funnell JL; Fink TD; Swaminathan A; Oudega M; Zha RH; Gilbert RJ
    Acta Biomater; 2023 Jan; 155():370-385. PubMed ID: 36423820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and development of pH-responsive polyurethane membranes for intravaginal release of nanomedicines.
    Kim S; Traore YL; Ho EA; Shafiq M; Kim SH; Liu S
    Acta Biomater; 2018 Dec; 82():12-23. PubMed ID: 30296620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coaxially electrospun fiber-based microbicides facilitate broadly tunable release of maraviroc.
    Ball C; Chou SF; Jiang Y; Woodrow KA
    Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():117-24. PubMed ID: 27040202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures.
    Blakney AK; Krogstad EA; Jiang YH; Woodrow KA
    Int J Nanomedicine; 2014; 9():2967-78. PubMed ID: 24971008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated non-viral gene delivery from coaxial electrospun fiber mesh scaffolds.
    Saraf A; Baggett LS; Raphael RM; Kasper FK; Mikos AG
    J Control Release; 2010 Apr; 143(1):95-103. PubMed ID: 20006660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in multiaxial electrospinning for drug delivery.
    Khalf A; Madihally SV
    Eur J Pharm Biopharm; 2017 Mar; 112():1-17. PubMed ID: 27865991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitro.
    Tyo KM; Vuong HR; Malik DA; Sims LB; Alatassi H; Duan J; Watson WH; Steinbach-Rankins JM
    Int J Pharm; 2017 Oct; 531(1):118-133. PubMed ID: 28797967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-responsive delivery of Griffithsin from electrospun fibers.
    Tyo KM; Duan J; Kollipara P; Dela Cerna MVC; Lee D; Palmer KE; Steinbach-Rankins JM
    Eur J Pharm Biopharm; 2019 May; 138():64-74. PubMed ID: 29698714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural protein-based electrospun nanofibers for advanced healthcare applications: progress and challenges.
    Agarwal A; Rao GK; Majumder S; Shandilya M; Rawat V; Purwar R; Verma M; Srivastava CM
    3 Biotech; 2022 Apr; 12(4):92. PubMed ID: 35342680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulation of T4 bacteriophage in electrospun poly(ethylene oxide)/cellulose diacetate fibers.
    Korehei R; Kadla JF
    Carbohydr Polym; 2014 Jan; 100():150-7. PubMed ID: 24188849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomedical Applications of Electrospun Nanofibers: Drug and Nanoparticle Delivery.
    Bhattarai RS; Bachu RD; Boddu SHS; Bhaduri S
    Pharmaceutics; 2018 Dec; 11(1):. PubMed ID: 30586852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional electrospun nanofibers for wound application - Novel insights into the control of drug release and antimicrobial activity.
    Wang J; Planz V; Vukosavljevic B; Windbergs M
    Eur J Pharm Biopharm; 2018 Aug; 129():175-183. PubMed ID: 29859280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrospun amorphous solid dispersions of poorly water-soluble drugs: A review.
    Yu DG; Li JJ; Williams GR; Zhao M
    J Control Release; 2018 Dec; 292():91-110. PubMed ID: 30118788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrospun solid dispersions of Maraviroc for rapid intravaginal preexposure prophylaxis of HIV.
    Ball C; Woodrow KA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4855-65. PubMed ID: 24913168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tunable Release of Multiclass Anti-HIV Drugs that are Water-Soluble and Loaded at High Drug Content in Polyester Blended Electrospun Fibers.
    Carson D; Jiang Y; Woodrow KA
    Pharm Res; 2016 Jan; 33(1):125-36. PubMed ID: 26286184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.